A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC
Clinical trial NCT03380130 · COMPLETED
Trial details
- NCT number
- NCT03380130
- Sponsor
- Clinica Universidad de Navarra, Universidad de Navarra
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2020-03-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.